ADAS-Cog 3 | ADAS-Cog 5 | ADAS-Cog 13 | |||||||
---|---|---|---|---|---|---|---|---|---|
Number of subjects | Score | CFB | Number of subjects | Score | CFB | Number of subjects | Score | CFB | |
Mild AD (non-enriched) | |||||||||
Baseline/screen | 97 | 15.95 ± 4.15 | 97 | 26.20 ± 5.31 | 97 | 29.91 ± 7.44 | |||
Month 6 | 95 | 16.95 ± 4.83 | 1.10 ± 3.85 | 95 | 27.62 ± 6.25 | 1.52 ± 4.32 | 95 | 31.86 ± 8.51 | 2.10 ± 4.79 |
Month 12 | 97 | 17.77 ± 5.29 | 1.82 ± 3.91 | 97 | 28.84 ± 6.75 | 2.64 ± 4.39 | 97 | 34.26 ± 10.43 | 4.35 ± 5.89 |
Month 24 | 40 | 18.68 ± 5.82 | 3.81 ± 5.12 | 40 | 30.27 ± 7.20 | 5.48 ± 6.13 | 38 | 37.17 ± 12.38 | 9.46 ± 9.15 |
Mild AD+ (enriched) | |||||||||
Baseline/screen | 90 | 16.24 ± 4.12 | 90 | 26.62 ± 5.23 | 90 | 30.52 ± 7.35 | |||
Month 6 | 88 | 17.17 ± 4.89 | 1.03 ± 3.92 | 88 | 27.92 ± 6.32 | 1.41 ± 4.37 | 88 | 32.36 ± 8.58 | 1.99 ± 4.84 |
Month 12 | 90 | 18.19 ± 5.17 | 1.96 ± 3.98 | 90 | 29.42 ± 6.59 | 2.80 ± 4.46 | 90 | 35.08 ± 10.34 | 4.57 ± 6.03 |
Month 24 | 37 | 19.15 ± 5.77 | 4.06 ± 5.23 | 35 | 30.79 ± 7.18 | 5.63 ± 6.34 | 35 | 37.99 ± 12.51 | 9.77 ± 9.40 |